Alternative Sites for Intramuscular Epinephrine Administration in Patients Without Legs
In patients without legs, administer the 0.3 mg intramuscular epinephrine dose into the deltoid muscle of the upper arm. While this is not the optimal site, it remains a viable alternative when the preferred thigh injection site is anatomically unavailable.
Rationale and Evidence
The 2020 American Heart Association guidelines clearly establish that injection of epinephrine into the lateral aspect of the thigh produces rapid peak plasma epinephrine concentrations 1. This is the gold standard because intramuscular injection into the anterolateral thigh (vastus lateralis) produces higher and more rapid peak plasma levels compared with injections administered intramuscularly or subcutaneously in the arm 2.
However, when the thigh is not available:
Primary Alternative: Deltoid Muscle
- Administer 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) intramuscularly into the deltoid muscle 2
- Use a needle long enough to ensure intramuscular penetration (at least 1/2 to 5/8 inch) 3
- The arm permits easy access for administration of epinephrine, though absorption is slower than thigh injection 2
Critical Dosing Parameters
- Repeat every 5-15 minutes as needed based on clinical response 1, 4
- Monitor closely for hemodynamic changes and response to therapy 1
- Between 7-18% of patients require more than one dose of epinephrine 4
Important Caveats
Do NOT inject into:
- Buttocks (risk of inadequate absorption and tissue injury) 3
- Digits, hands, or feet (risk of tissue necrosis from vasoconstriction) 3
If Deltoid Injection is Inadequate
Consider transitioning to intravenous administration if:
- Patient fails to respond to 2-3 intramuscular doses
- Severe or rapidly progressive anaphylaxis is present
- IV access is already established
IV dosing: 0.05-0.1 mg (1:10,000 dilution) as a slow bolus, or continuous infusion at 5-15 μg/min 1. This is a Class 2a recommendation when IV access is available in anaphylactic shock 1.
Alternative Routes in Extremis
While not standard, the evidence mentions these options when traditional routes fail:
- Intraosseous (IO) epinephrine is likely effective at comparable doses, though not specifically studied in anaphylaxis 1
- Sublingual injection has been reported anecdotally if IV access cannot be obtained 2
Key Clinical Pitfalls
- Do not delay epinephrine administration while searching for the "perfect" site—immediate administration takes priority over optimal site selection
- Avoid subcutaneous injection in the arm—this produces inadequate plasma levels compared to intramuscular administration 5
- Do not use the same injection site repeatedly—rotate sites to prevent tissue necrosis from vasoconstriction 3
- There is no absolute contraindication to epinephrine in anaphylaxis—even in elderly patients or those with cardiac disease, the benefits outweigh risks 6, 7
The fundamental principle remains: epinephrine is the cornerstone of anaphylaxis treatment 1, 4, and any intramuscular site is superior to withholding or delaying this life-saving medication.